Skip to content

Relationship Between Endoplasmic Reticulum Stress and Pain in Patients With Endometriosis

Endoplasmic Reticulum Stress and Endometriosis Releated Pain

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04440397
Enrollment
86
Registered
2020-06-19
Start date
2020-03-17
Completion date
2020-08-04
Last updated
2020-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis, Endometriosis-related Pain, Endoplasmic Reticulum Stress

Brief summary

The correlation between painful symptoms (dysmenorrhea, dysparonia, dysuria, chronic pelvic pain) symptoms and endoplasmic reticulum stress was investigated in 86 patients diagnosed with endometriosis. For this, xbp-1 (x box binding protein-1) level was measured in patients. XBP-1 is an endoplasmic reticulum stress indicator and is known to be involved in pain pathogenesis.

Detailed description

Women between the ages of 18-50 who were diagnosed with endometriosis by surgery and ultrasound, without known rheumatological or metabolic diseases were included in the study. Most of the patients are composed of newly diagnosed patients.

Interventions

OTHERxbp-1 - endometriosis patients group

Patients diagnosed with endometriosis by surgery and ultrasound and whose xbp-1 level was examined

Sponsors

Kanuni Sultan Suleyman Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* diagnosed endometriosis with ultrasound or surgery * no metabolic diseases * no rheumatological diseases

Exclusion criteria

* Immune modulator, hormonal, anti-inflammatory use history in the last 3 months

Design outcomes

Primary

MeasureTime frame
Evaluation of the correlations between the results of XBP-1 levels and the stages and pain symptoms of endometriosis.5 months

Secondary

MeasureTime frame
serum XBP-1levels in patients wit endometriosis5 months

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026